You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報15,510點 跌23點; 恆生科技指數半日收報3,037點 跌6點 藥明康德升逾7% 長建、ASMPT創新高
恆指半日收15,510點,跌23點或0.1%。恆生科技指數報3,037點,跌6點或0.2%。國指升0.000.0%,報5,219點。 活躍重磅股表現: 美團(03690.HK) 收64.65元,上升2.2%; 港交所(00388.HK) 收230.4元,下跌1.3%; 平安(02318.HK) 收32.05元,上升0.8%; 友邦(01299.HK) 收60.15元,上升0.7%; 騰訊(00700.HK) 收278元,下跌0.5%; 建行(00939.HK) 收4.62元,上升0.2%; 阿里巴巴(09988.HK) 收70.55元,下跌0.2%; 異動恆指及國指成份股: 藥明康德(02359.HK) 收47.05元,上升7.7%; 龍湖(00960.HK) 收8.31元,下跌4.5%; 小鵬汽車(09868.HK) 收30.9元,下跌4%; 藥明生物(02269.HK) 收17.44元,上升3.9%; 恆隆地產(00101.HK) 收8.8元,下跌3.6%; 長建(01038.HK) 收48.15元,上升2.4%,創新高; 異動綜合中小型股: 開拓藥業-B(09939.HK) 收1.52元,下跌16.5%; 金輝控股(09993.HK) 收2.57元,下跌14.9%; 泉峰控股(02285.HK) 收14元,下跌12.6%; 科濟藥業-B(02171.HK) 收4.37元,上升11.8%; 海昌海洋公園(02255.HK) 收0.7元,下跌10.3%; 來凱醫藥-B(02105.HK) 收3.33元,下跌10.2%; ASMPT(00522.HK) 收86.3元,上升1.2%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account